Acadia Healthcare Company closed at $34.79 on Nov 5, up 7.88%, 2.3% below its 52-week closing high. Volume of 5.5M shares was 3.09× its 20-day average (well above normal).
Split-adjusted performance: +19.0% over one month, +42.2% over six months, +68.4% over one year.
In the quarter ended Jun 30, 2026, revenue was $865.84M, down 0.4% from a year earlier, with a net margin of 1.3%.
Short interest was 20.9M shares at the Oct 15 settlement, down 8.0% from the prior report (23.0% of float, 13.7 days to cover).